Two-Year Prevalence and Recovery Rate of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19
Open Access
- 1 September 2022
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 148 (9) , 889-891
Abstract
Before the advent of the Omicron variant, smell and taste dysfunction were among the most commonly reported symptoms of mildly symptomatic COVID-19.1,2 Moreover, smell and/or taste dysfunction are prevalent symptoms of long-term COVID-19, with 7% of patients being functionally anosmic 1 year after SARS-CoV-2 infection.3 Given the high case rate of COVID-19, it is important to estimate the long-term persistence of these symptoms. We previously described the prevalence of an altered sense of smell or taste in mildly symptomatic patients at onset, 4 weeks, 8 weeks, and 6 months after COVID-19.1,4,5 The aim of the present study was to estimate the 2-year prevalence and recovery rate of smell or taste dysfunction in the same series of patients.Keywords
This publication has 6 references indexed in Scilit:
- Coronavirus disease 2019 (COVID‐19)–related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome–coronavirus‐2 (SARS‐CoV‐2) Omicron variantInternational Forum of Allergy & Rhinology, 2022
- Altered smell and taste: Anosmia, parosmia and the impact of long Covid-19PLOS ONE, 2021
- High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-COVID-19 patients: a matched case-control study with one-year follow-up using a comprehensive psychophysical evaluationRhinology journal, 2021
- Six-Month Psychophysical Evaluation of Olfactory Dysfunction in Patients with COVID-19Chemical Senses, 2021
- Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19JAMA Otolaryngology–Head & Neck Surgery, 2020
- Alterations in Smell or Taste in Mildly Symptomatic Outpatients With SARS-CoV-2 InfectionJAMA, 2020